Skip to main content

UBS Group AG

Position in ELTX — Elicio Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ELTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$158,037
-$202,952 QoQ
Shares Held
40,419
+19.7% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 48 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ELTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. ELTX ranks #348 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ELTX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $158,037 40,419
2026-03-31 $360,989 33,769
2025-12-31 $254,846 32,016
2025-09-30 $76,787 7,019
2025-06-30 $46,497 6,023
2025-03-31 $130,579 21,198
2024-12-31 $86 17
2024-09-30 $4,264 848
2024-06-30 $69 17
2024-03-31 $121 16
2023-12-31 $133 16
2023-09-30 $135 16
2023-06-30 $6,127 645
2023-03-31 ANGN 14,492
2022-12-31 ANGN 9,919
2022-09-30 ANGN 7,240
2022-06-30 ANGN 10,969
2022-03-31 ANGN 466
2021-12-31 ANGN 8,537
2021-06-30 ANGN 217
2021-03-31 ANGN 1,630